Feinberg AP. The key role of epigenetics in human disease prevention and mitigation. NEJM. 2018;378:1323–34.
Portela A, Esteller M. Epigenetic modifications and human disease. Nat Biotechnol. 2010;28:1057–68.
Jang HS, Shin WJ, Lee JE, Do JT. CpG and Non-CpG methylation in epigenetic gene regulation and brain function. Genes. 2017;8:148.
Perkins DJ, Patel MC, Blanco JCG, Vogel SN. Epigenetic mechanisms governing innate inflammatory responses. J Interferon Cyt Res. 2016;36:454–61.
Stylianou E. Epigenetics of chronic inflammatory diseases. J Inflamm Res. 2018;12:1–14.
Zicari S, Sessa L, Cotugno N, et al. Immune activation, inflammation, and non-AIDS co-morbidities in HIV-infected patients under long-term ART. Viruses. 2019;11:200.
Relton CL, Davey SG. Mendelian randomization: applications and limitations in epigenetic studies. Epigenomics. 2015;7:1239–43.
Triant VA. Cardiovascular disease and HIV infection. Curr HIV/AIDS Rep. 2013;10:199–206.
Naicker S, Rahmanian S, Kopp JB. HIV and chronic kidney disease. Clin Nephrol. 2015;83:32–8.
Hessol NA, Strickler HD. Cancer risk in people living with HIV. Lancet HIV. 2017;4:e477–9.
Chiao EY, Coghill A, Kizub D, et al. The effect of non-AIDS-defining cancers on people living with HIV. Lancet Oncol. 2021;22(6):e240–53. https://doi.org/10.1016/S1470-2045(21)00137-6.
Lurain K, Yarchoan R, Ramaswami R. The changing face of HIV-associated malignancies: advances, opportunities, and future directions. Am Soc Clin Oncol Educ Book. 2019;39:36–40.
Clifford DB, Ances BM. HIV-associated neurocognitive disorder. Lancet Infect Dis. 2013;13:976–86.
Hagberg L, Cinque P, Gisslen M, et al. Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infection. AIDS Res Ther. 2010;7:15.
Fitzpatrick ME, Kunisaki KM, Morris A. Pulmonary disease in HIV-infected adults in the era of antiretroviral therapy. AIDS. 2018;32:277–92.
Sherman KE, Rockstroh J, Thomas D. Human immunodeficiency virus and liver disease: an update. Hepatology. 2015;62:1871–82.
Kauder SE, Bosque A, Lindqvist A, Planelles V, Verdin E. Epigenetic regulation of HIV-1 latency by cytosine methylation. PLoS Pathog. 2009;5:e1000495.
Kint S, Trypsteen W, De Spiegelaere W, et al. Underestimated effect of intragenic HIV-1 DNA methylation on viral transcription in infected individuals. Clin Epigenet. 2020;12:36.
Oriol-Tordera B, Berdasco M, Llano A, et al. Methylation regulation of Antiviral host factors, Interferon Stimulated Genes (ISGs) and T-cell responses associated with natural HIV control. PLoS Pathog. 2020;16:e1008678.
Abdel-Hameed EA, Ji H, Shata MT. HIV-induced epigenetic alterations in host cells. Adv Exp Med Biol. 2016;879:27–38.
Justice AC, Dombrowski E, Conigliaro J, et al. Veterans aging cohort study (VACS): overview and description. Med Care. 2006;44:S13-24.
Hernandez Cordero AI, Yang CX, Obeidat M, et al. DNA methylation is associated with airflow obstruction in patients living with HIV. Thorax. 2021;76:448.
Maschke M, Kastrup O, Esser S, Ross B, Hengge U, Hufnagel A. Incidence and prevalence of neurological disorders associated with HIV since the introduction of highly active antiretroviral therapy (HAART). J Neurol Neurosurg Psychiatry. 2000;69:376–80.
Shiau S, Arpadi SM, Shen Y, et al. Epigenetic aging biomarkers associated with cognitive impairment in older African American adults with HIV. Clin Infect Dis. 2021;73:1982–91.
Shiau S, Cantos A, Ramon CV, et al. Epigenetic age in young african American adults with perinatally acquired HIV. J Acquir Immune Defic Syndr. 2021;87:1102–9.
Shiau S, Strehlau R, Shen J, et al. Biomarkers of aging in HIV-infected children on suppressive antiretroviral therapy. J Acquir Immune Defic Syndr. 2018;78:549–56.
Zhang X, Justice AC, Hu Y, et al. Epigenome-wide differential DNA methylation between HIV-infected and uninfected individuals. Epigenetics. 2016;11:750–60.
Blazkova J, Murray D, Justement JS, et al. Paucity of HIV DNA methylation in latently infected, resting CD4+ T cells from infected individuals receiving antiretroviral therapy. J Virol. 2012;86:5390–2.
Blazkova J, Trejbalova K, Gondois-Rey F, et al. CpG methylation controls reactivation of HIV from latency. PLoS Pathog. 2009;5:e1000554.
Pino M, Pereira Ribeiro S, Pagliuzza A, et al. Increased homeostatic cytokines and stability of HIV-infected memory CD4 T-cells identify individuals with suboptimal CD4 T-cell recovery on-ART. PLoS Pathog. 2021;17:e1009825.
Chen J, Huang Y, Hui Q, et al. Epigenetic associations with estimated glomerular filtration rate among men with human immunodeficiency virus infection. Clin Infect Dis. 2020;70:667–73.
Rappaport J, Volsky DJ. Role of the macrophage in HIV-associated neurocognitive disorders and other comorbidities in patients on effective antiretroviral treatment. J Neurovirol. 2015;21:235–41.
Corley MJ, Dye C, D’Antoni ML, et al. Comparative DNA methylation profiling reveals an immunoepigenetic signature of HIV-related cognitive impairment. Sci Rep. 2016;6:33310.
Angelovich TA, Churchill MJ, Wright EJ, Brew BJ. New potential axes of HIV neuropathogenesis with relevance to biomarkers and treatment. Curr Top Behav Neurosci. 2021;50:3–39. https://doi.org/10.1007/7854_2019_126.
Kalra S, Kalra B, Agrawal N, Unnikrishnan AG. Understanding diabetes in patients with HIV/AIDS. Diabetol Metab Syndr. 2011;3:2.
Mathur R, Hui Q, Huang Y, et al. DNA methylation markers of type 2 diabetes mellitus among male veterans with or without human immunodeficiency virus infection. J Infect Dis. 2019;219:1959–62.
Xiang Y, Wang Z, Hui Q, Gwinn M, Vaccarino V, Sun YV. DNA methylation of TXNIP independently associated with inflammation and diabetes mellitus in twins. Twin Res Hum Genet. 2021. https://doi.org/10.1017/thg.2021.42.
Mamary EM, Bahrs D, Martinez S. Cigarette smoking and the desire to quit among individuals living with HIV. AIDS Patient Care STDS. 2002;16:39–42.
Niaura R, Shadel WG, Morrow K, Tashima K, Flanigan T, Abrams DB. Human immunodeficiency virus infection, AIDS, and smoking cessation: the time is now. Clin Infect Dis. 2000;31:808–12.
Palacio H, Hilton JF, Canchola AJ, Greenspan D. Effect of cigarette smoking on HIV-related oral lesions. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;14:338–42.
Royce RA, Winkelstein W Jr. HIV infection, cigarette smoking and CD4+ T-lymphocyte counts: preliminary results from the San Francisco Men’s Health Study. AIDS. 1990;4:327–33.
Stall RD, Greenwood GL, Acree M, Paul J, Coates TJ. Cigarette smoking among gay and bisexual men. Am J Public Health. 1999;89:1875–8.
Wallace JM, Rao AV, Glassroth J, et al. Respiratory illness in persons with human immunodeficiency virus infection. The pulmonary complications of HIV Infection Study Group. Am Rev Respir Dis. 1993;148:1523–9.
Rahmanian S, Wewers ME, Koletar S, Reynolds N, Ferketich A, Diaz P. Cigarette smoking in the HIV-infected population. Proc Am Thorac Soc. 2011;8:313–9.
Zhang X, Hu Y, Aouizerat BE, et al. Machine learning selected smoking-associated DNA methylation signatures that predict HIV prognosis and mortality. Clin Epigenetics. 2018;10:155.
Baum MK, Rafie C, Lai S, Sales S, Page B, Campa A. Crack-cocaine use accelerates HIV disease progression in a cohort of HIV-positive drug users. J Acquir Immune Defic Syndr. 2009;50:93–9.
Arnsten JH, Demas PA, Grant RW, et al. Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. J Gen Intern Med. 2002;17:377–81.
Shu C, Justice AC, Zhang X, et al. DNA methylation mediates the effect of cocaine use on HIV severity. Clin Epigenet. 2020;12:140.
Justice AC, Modur SP, Tate JP, et al. Predictive accuracy of the Veterans Aging Cohort Study index for mortality with HIV infection: a North American cross cohort analysis. J Acquir Immune Defic Syndr. 1999;2013(62):149–63.
Calkins KL, Lesko CR, Chander G, Moore RD, Lau B. Influence of injection drug use-related HIV acquisition on CD4 response to first antiretroviral therapy regimen among virally suppressed individuals. J Acquir Immune Defic Syndr. 1999;2018(77):317–24.
Cescon A, Chan K, Raboud JM, et al. Significant differences in clinical outcomes between HIV-hepatitis C virus coinfected individuals with and without injection drug use history. AIDS. 2014;28:121–7.
Lopez Angel CJ, Pham EA, Du H, et al. Signatures of immune dysfunction in HIV and HCV infection share features with chronic inflammation in aging and persist after viral reduction or elimination. Proc Natl Acad Sci. 2021;118:e2022928118.
Zhang X, Hu Y, Justice AC, et al. DNA methylation signatures of illicit drug injection and hepatitis C are associated with HIV frailty. Nat Commun. 2017;8:2243.
Fransquet PD, Wrigglesworth J, Woods RL, Ernst ME, Ryan J. The epigenetic clock as a predictor of disease and mortality risk: a systematic review and meta-analysis. Clin Epigenet. 2019;11:62.
Moron-Lopez S, Urrea V, Dalmau J, et al. The genome-wide methylation profile of CD4+ T cells from individuals with human immunodeficiency virus (HIV) identifies distinct patterns associated with disease progression. Clin Infect Dis. 2021;72:e256–64.
Shu C, Justice AC, Zhang X, et al. DNA methylation biomarker selected by an ensemble machine learning approach predicts mortality risk in an HIV-positive veteran population. Epigenetics. 2021;16:741–53.
HIV and Older Americans. Centers for disease control and prevention. https://www.cdc.gov/hiv/group/age/olderamericans/index.html. Accessed 18 Oct 2021.
Piekna-Przybylska D, Sharma G, Maggirwar SB, Bambara RA. Deficiency in DNA damage response, a new characteristic of cells infected with latent HIV-1. Cell Cycle. 2017;16:968–78.
Effros RB, Allsopp R, Chiu CP, et al. Shortened telomeres in the expanded CD28-CD8+ cell subset in HIV disease implicate replicative senescence in HIV pathogenesis. AIDS. 1996;10:F17-22.
Zanet DL, Thorne A, Singer J, et al. Association between short leukocyte telomere length and HIV infection in a cohort study: no evidence of a relationship with antiretroviral therapy. Clin Infect Dis. 2014;58:1322–32.
Dinkins C, Pilli M, Kehrl JH. Roles of autophagy in HIV infection. Immunol Cell Biol. 2015;93:11–7.
Nardacci R, Ciccosanti F, Marsella C, Ippolito G, Piacentini M, Fimia GM. Role of autophagy in HIV infection and pathogenesis. J Intern Med. 2017;281:422–32.
Hunt M, Payne BAI. Mitochondria and ageing with HIV. Curr Opin HIV AIDS. 2020;15:101–9.
Cohen J, Torres C. HIV-associated cellular senescence: a contributor to accelerated aging. Ageing Res Rev. 2017;36:117–24.
Horvath S, Raj K. DNA methylation-based biomarkers and the epigenetic clock theory of ageing. Nat Rev Genet. 2018;19:371–84.
Teschendorff AE, Menon U, Gentry-Maharaj A, et al. Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer. Genome Res. 2010;20:440–6.
Numata S, Ye T, Hyde TM, et al. DNA methylation signatures in development and aging of the human prefrontal cortex. Am J Hum Genet. 2012;90:260–72.
Bocklandt S, Lin W, Sehl ME, et al. Epigenetic predictor of age. PLoS ONE. 2011;6:e14821.
Horvath S, Levine AJ. HIV-1 infection accelerates age according to the epigenetic clock. J Infect Dis. 2015;212:1563–73.
Gross Andrew M, Jaeger Philipp A, Kreisberg Jason F, et al. Methylome-wide analysis of chronic HIV infection reveals five-year increase in biological age and epigenetic targeting of HLA. Mol Cell. 2016;62:157–68.
Rickabaugh TM, Baxter RM, Sehl M, et al. Acceleration of age-associated methylation patterns in HIV-1-infected adults. PLoS ONE. 2015;10:e0119201.
Yang CX, Schon E, Obeidat M, et al. Occurrence of accelerated epigenetic aging and methylation disruptions in human immunodeficiency virus infection before antiretroviral therapy. J Infect Dis. 2021;223:1681–9.
Chen BH, Marioni RE, Colicino E, et al. DNA methylation-based measures of biological age: meta-analysis predicting time to death. Aging (Albany NY). 2016;8:1844–65.
Nelson KN, Hui Q, Rimland D, et al. Identification of HIV infection-related DNA methylation sites and advanced epigenetic aging in HIV-positive, treatment-naive U.S. veterans. AIDS. 2017;31:571–5.
Esteban-Cantos A, Montejano R, Rodríguez-Centeno J, et al. Longitudinal changes in epigenetic age acceleration in aviremic HIV-infected recipients of long-term antiretroviral treatment. J Infect Dis. 2021. https://doi.org/10.1093/infdis/jiab338.
Levine ME, Lu AT, Quach A, et al. An epigenetic biomarker of aging for lifespan and healthspan. Aging (Albany NY). 2018;10:573–91.
Lu AT, Quach A, Wilson JG, et al. DNA methylation GrimAge strongly predicts lifespan and healthspan. Aging (Albany NY). 2019;11:303–27.
Esteban-Cantos A, Rodríguez-Centeno J, Barruz P, et al. Epigenetic age acceleration changes 2 years after antiretroviral therapy initiation in adults with HIV: a substudy of the NEAT001/ANRS143 randomised trial. Lancet HIV. 2021;8:e197–205.
Raffi F, Babiker AG, Richert L, et al. Ritonavir-boosted darunavir combined with raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial. Lancet. 2014;384:1942–51.
Sundermann EE, Hussain MA, Moore DJ, et al. Inflammation-related genes are associated with epigenetic aging in HIV. J Neurovirol. 2019;25:853–65.
Hsu DC, Ma YF, Hur S, et al. Plasma IL-6 levels are independently associated with atherosclerosis and mortality in HIV-infected individuals on suppressive antiretroviral therapy. AIDS. 2016;30:2065–74.